Abstract:Abstract Background Oxidative stress leads to adverse atrial remodeling in diabetes mellitus. AMP-activated protein kinase (AMPK) agonists have been shown to prevent cardiomyocytes from oxidative stress by improving mitochondrial function, but their underlying mechanisms are not completely understood. This study investigated the molecular changes and their underlying regulatory mechanisms by the AMPK agonists, metformin and AICA ribonucleotide (AICAR). Methods Mouse atrial cardiomyocytes (HL-1 cells) and rats with type 2 diabetes mellitus (DM) were used as study models. A total of 40 rats were randomly divided into control, DM alone, DM treated with metformin, AICAR, or metformin with the AMPK inhibitor Compound C. Echocardiographic, hemodynamic, and electrophysiological measurements were made in vivo . Reactive oxygen species (ROS) production rate and mitochondrial membrane potential (MMP) levels were performed in vitro . Protein expression of SOD, COX43 and mitochondrial biogenesis related proteins were measured using Western blotting. Results Compared with controls, the diabetes group demonstrated larger left atrial diameter and fibrosis area associated with a higher incidence of inducible atrial fibrillation (AF). Lower Mn-SOD, COX42, and mitochondrial biogenesis (PGC-1α, NRF1 and TFAM)-related proteins were observed, accompanied by mitochondrial swelling. Metformin treatment led to reversal of structural remodeling and lower inducible AF incidence, which were associated with higher Mn-SOD, COX42, and biogenesis-related proteins as well as improvement in the structure and function of mitochondria. Similar protective changes were observed following AICAR or metformin with Compound C treatment. In HL-1 cell line, compared with controls, the DM group demonstrated higher mitochondrial ROS production rat and lower MMP levels. Mn-SOD, COX42, and mitochondrial biogenesis (PGC-1α, NRF1 and TFAM)-related proteins expression were consistent with animal levels. Conclusions Diabetes mellitus induces adverse atrial structural, electrophysiological remodeling, and mitochondrial damage and dysfunction. Metformin prevented these abnormalities through activation of the AMPK signaling pathway.

Metformin alleviates lead-induced mitochondrial fragmentation via AMPK/Nrf2 activation in SH-SY5Y cells

Metformin Attenuates Cadmium-Induced Neuronal Apoptosis in Vitro Via Blocking ROS-dependent PP5/AMPK-JNK Signaling Pathway

Identification and Validation of Metformin Protects Against PM2.5-induced Macrophages Cytotoxicity by Targeting Toll Like Receptor Pathway

Metformin Attenuates Manganese-Induced Oxidative Stress in N27-A Dopaminergic Neuronal Cells

ATF5-mediated mitochondrial unfolded protein response protects against Pb-induced mitochondria damage in SH-SY5Y cell

Lead Disrupts Mitochondrial Morphology and Function Through Induction of ER Stress in Model of Neurotoxicity

Metformin leads to accumulation of reactive oxygen species by inhibiting the NFE2L1 expression in human hepatocellular carcinoma cells

Metformin protects diabetes-induced atrial mitochondrial from oxidative stress and improves mitochondrial biogenesis via the AMPK signaling pathway

Metformin attenuates cadmium-induced degeneration of spiral ganglion neuron via restoring autophagic flux in primary culture

Lead exposure represses mitochondrial metabolism by activation of heme-binding protein BACH1 in differentiated SH-SY5Y cell

Acute Administration of Metformin Protects Against Neuronal Apoptosis Induced by Cerebral Ischemia-Reperfusion Injury via Regulation of the AMPK/CREB/BDNF Pathway

Regulation of mitophagy by metformin improves the structure and function of retinal ganglion cells following excitotoxicity-induced retinal injury

Metformin Protects PC12 Cells and Hippocampal Neurons from H2O2‐induced Oxidative Damage Through Activation of AMPK Pathway

Metformin protects high glucose‐cultured cardiomyocytes from oxidative stress by promoting NDUFA13 expression and mitochondrial biogenesis via the AMPK signaling pathway

Metformin induces pyroptosis in leptin receptor-defective hepatocytes via overactivation of the AMPK axis

Metformin Attenuates Hypoxia-induced Endothelial Cell Injury by Activating the AMP-Activated Protein Kinase Pathway

Metformin ameliorates arsenic trioxide hepatotoxicity via inhibiting mitochondrial complex I

Metformin protects against pericyte apoptosis and promotes neurogenesis through suppressing JNK p38 MAPK signalling activation in ischemia/reperfusion injury

Protective effect of metformin on PC12 cell injury induced by hypoxia

Metformin Alleviates Hydrogen Peroxide-Induced Inflammation and Oxidative Stress Via Inhibiting P2X7R Signaling in Spinal Cord Tissue Cells Neurons

Activation of AMPK signalling by Metformin: Implication an important molecular mechanism for protecting against mice silicosis via inhibited endothelial cell-to-mesenchymal transition by regulating oxidative stress and apoptosis